Hypertension News

WASHINGTON — In patients with treatment-resistant hypertension, despite taking one to three BP-lowering medications, radiofrequency renal denervation conferred BP reduction out to 36 months, researchers reported.

Patients with pulmonary hypertension who underwent kidney transplantation had similar posttransplant outcomes at 5 years compared with those without pretransplant pulmonary hypertension, researchers reported in Pulmonary Circulation.

A newly released Morbidity and Mortality Weekly Report shows a 41.8% increase in incident end-stage kidney disease cases and an 118.7% increase in prevalent cases across the United States between 2000 and 2019.

Compared with white patients, Black patients had lower odds of receiving statins for secondary cardiovascular disease prevention after kidney transplant.

Certain changes to preexisting models that predict risk for cardiovascular events in the general population can help clinicians predict risk for atherosclerotic CVD in patients with chronic kidney disease.

Hypertension control was elusive in many Black or African American populations, even when health care providers followed race-based guidelines for the condition, a study showed.

The combination of healthy lifestyle and adherence to antihypertensive medications was associated with decreased risk for mortality in patients with hypertension, according to data in JAMA Network Open.

The rate of hospitalization for hypertensive crisis increased in recent years, but the odds of death during hospitalization decreased and was similar for men and women, researchers reported.

In a real-world outpatient population, mineralocorticoid receptor antagonist use in patients with chronic kidney disease was associated with lower rates of renal replacement therapy initiation compared with nonuse, researchers reported.

Chronic hypertension is a substantial contributor to maternal deaths in the United States, with particular risk among Black women, according to a study published in Hypertension.